Liver Diseases Therapeutics Market Forecast 2024-2033: Projected CAGR, Key Drivers, And Trends

Overview and Scope
Liver disease therapeutics refers to the treatment of numerous types of liver illnesses, diseases brought on by viruses, including hepatitis A, B, and C. These diseases are mainly caused by consuming more alcohol.

Sizing and Forecast
The liver diseases therapeutics market size has grown strongly in recent years. It will grow from $13.02 billion in 2023 to $14.07 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to high prevalence of liver diseases, alcohol consumption patterns, advancements in diagnostics, obesity and metabolic syndrome, awareness and screening programs, government initiatives for hepatitis control..

The liver diseases therapeutics market size is expected to see strong growth in the next few years. It will grow to $18.98 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to precision medicine approaches, innovations in rna therapeutics, focus on fibrosis treatments, patient advocacy and support groups, development of vaccines for hepatitis, regulatory support for orphan drugs.. Major trends in the forecast period include advancements in treatment for hepatitis c, emergence of novel therapies for liver fibrosis, exploration of immunotherapies, telemedicine and remote monitoring, focus on nutritional interventions..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Segmentation & Regional Insights
The liver diseases therapeutics market covered in this report is segmented –

1) By Disease Type: Hepatitis, Non-Alcoholic Fatty Liver Disease, Alcohol-Induced, Liver Cancer
2) By Treatment: Antiviral, Vaccines, Chemotherapy, Immunosuppressive Agents, Corticosteroids
3) By End User: Hospitals, Ambulatory Surgery Centers, Other End Users

North America was the largest region in the liver diseases therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the liver diseases therapeutics market report during the forecast period. The regions covered in the liver diseases therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7969&type=smp

Major Driver Impacting Market Growth
The rising prevalence of liver diseases is expected to propel the growth of the liver disease therapeutics market going forward. Liver disease refers to any condition that has been affecting the liver. Liver disease therapeutics help in treating liver diseases through various treatments. For instance, in September 2023, according to reports shared by the American Liver Foundation, a US-based non-profit organization, liver disease had been detected in 4.5 million people (1.8%) in the US, and 51,642 adults in the U.S. died from liver disease in 2020. Therefore, the rising prevalence of liver diseases drives the growth of the liver disease therapeutics market.

Key Industry Players
Major companies operating in the liver diseases therapeutics market report are Astellas Pharma Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., Novartis AG, GlaxoSmithKline plc, Abbott Laboratories Inc., Pfizer Inc., Sanofi SA, Johnson & Johnson Services Inc., Bayer AG, AbbVie Inc., Takeda Pharmaceutical Company Limited, Valeant Pharmaceuticals, Watson Pharmaceuticals Inc., AstraZeneca plc, Gilead Sciences Inc., Endo International plc, Alnylam Pharmaceuticals Inc., Provectus Biopharmaceuticals Inc., Intercept Pharmaceuticals Inc., Conatus Pharmaceuticals Inc., CymaBay Therapeutics Inc., Viking Therapeutics Inc., Madrigal Pharmaceuticals Inc., NGM Biopharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Enanta Pharmaceuticals Inc

The liver diseases therapeutics market report table of contents includes:

1. Executive Summary

2. Liver Diseases Therapeutics Market Characteristics

3. Liver Diseases Therapeutics Market Trends And Strategies

4. Liver Diseases Therapeutics Market – Macro Economic Scenario

5. Global Liver Diseases Therapeutics Market Size and Growth

.
.
.

31. Global Liver Diseases Therapeutics Market Competitive Benchmarking

32. Global Liver Diseases Therapeutics Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Liver Diseases Therapeutics Market

34. Liver Diseases Therapeutics Market Future Outlook and Potential Analysis

35. Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info 

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
Twitter: https://twitter.com/tbrc_info 
Facebook: https://www.facebook.com/TheBusinessResearchCompany 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ 
Blog: https://blog.tbrc.info/ 
Healthcare Blog: https://healthcareresearchreports.com/ 
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model